An Australian innovation in 3D printing could soon help in the fight against cancer.

Sydney based start-up Inventia has built a new 3D bio-printer that it says removes the need for time-consuming manual labour by medical lab workers.

Known as Rastrum, the pink printer emulates ink-jet technology to print human cells at a rapid rate – quickly cultivating realistic tumours for testing cancer drugs.

It can also conduct multiple experiments at the same time.

“One of the comments we had from a researcher was he was able to produce more cell models with Rastrum in a few weeks than he previously produced in an entire PhD,” Cameron Ferris, Inventia’s chief operating officer, said.

“We hope that this will turbocharge cancer research.”

Kaylene Simpson, head of the Victorian Centre for Functional Genomics (VCFG), said the machine will have a profound impact on the centre’s studies.

“It’s a game changer for us in a discovery-based science … we can screen through thousands of drugs,” she said.

Image Credit:    Cameron Gooley

News This Week

Sugar-Coated Nanoparticles Boost Cancer Drug Efficacy

A team of researchers at the University of Mississippi has discovered that coating cancer treatment carrying nanoparticles in a sugar-like material increases their treatment efficacy. They reported their findings in Advanced Healthcare Materials. Over a tenth of breast [...]

Nanomotors: Where Are They Now?

First introduced in 2004, nanomotors have steadily advanced from a scientific curiosity to a practical technology with wide-ranging applications. This article explores the key developments, recent innovations, and major uses of nanomotors today. A [...]